Vectorite Biomedical Inc. (TPEX:4170)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.45
+0.25 (2.05%)
Sep 15, 2026, 2:00 PM CST

Vectorite Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
77613635935363363
Market Cap Growth
-87.14%-3.45%-32.08%157.56%0%0%
Enterprise Value
-66437442728322322
Last Close Price
13.0014.0014.5021.3514.0114.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
4.846.37---43.41
PS Ratio
1.409.9810.9916.738.4612.61
PB Ratio
0.151.261.632.170.820.78
P/TBV Ratio
0.151.261.662.290.870.82
P/FCF Ratio
----26.27-
P/OCF Ratio
---719.9724.68-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-7.127.6513.047.5111.20
EV/FCF Ratio
----23.32-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.00----
Net Debt / Equity Ratio
-0.32-0.35-0.47-0.47-0.48-0.51
Net Debt / EBITDA Ratio
10.2712.2310.7429.219.859.23
Net Debt / FCF Ratio
19.8417.4012.8858.92-15.463.54
Asset Turnover
0.120.130.130.120.090.07
Inventory Turnover
2.212.673.295.316.994.97
Quick Ratio
9.0810.7312.9116.4514.1014.53
Current Ratio
10.0511.8514.0617.5314.9315.07
Return on Equity (ROE)
26.13%21.98%-9.77%-1.52%-5.83%2.05%
Return on Assets (ROA)
-3.03%-2.97%-3.75%-2.20%-3.98%-6.15%
Return on Capital Employed (ROCE)
-4.50%-4.40%-6.50%-3.70%-6.80%-8.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
154.41%15.69%-6.31%-0.71%-7.28%2.30%
FCF Yield
-10.93%-1.60%-2.26%-0.37%3.81%-18.63%
Buyback Yield / Dilution
-0.65%-0.53%0.14%--1.84%-47.01%